Aggression though not easily defined is always a psychological and social menace. In animal observation' aggression has been related to predatory, fear induced, irritable, territorial, maternal, sex-related, ii.termale and instrumental conditions (Freedman et al, 1975) . In human beings, aggression has been associated with genetic factors, sex, testosterone level, mental retardation, epilepsy, encephalitis, brain tumors, organic psychosis, schizophrenia, affective psychosis, personality disorders, alcoholism and various other conditions. As safety of the patient ; s well as others is jeopardised due to aggression, control of aggressive behaviour in any condition, gets a priority over all other psymp'oms. Various methods including isolation, admission, E.G.T., antipsychotic drugs, trai.quilisers, hormones, psychosurgery behaviour therapy etc. have been tried for the control of aggression. Lithim carbonate is a new introduction in this field. A large number of reports have claimed that lithium has an antiaggressive effect even in patient not suffering from affective psychosis. These claims have covered a wide variety of patients of different clinical diagnosis in various situations. Lithium has shown its efficacy in non-psychotic imprisoned violent offenders (Johnson and Johnson, 1978) , mixed group of hospitalised patients showing aggressive behaviour (Johnson and Johnson, 1978) , patients of Huntington's Chorea showing aggression (Leonard et al, 1974) and in mentally retarded showing aggressive behaviour (Dak, 1980; Johnson and Johnson, 1978, VVorral, 1975 
AIMS
To evaluate an tiaggressive effect of lithium carbonate.
MATERIAL AND METHOD
This study was carried out at the out-patient department of psychiatry ofK.E.M. Hospital, Bombay. Patients, suffering from different psychiatric illnesses, but showing marked aggressive behaviour which was not controlled by the appropriate treatment with antipsychotics, E.G.T. anticpileptics, tranquiliscrs given for adequate duration of time, were included in this study. The patients stayed in their home atmosphere being in the same social surroundings before and during the treatment. One relative (>f the patient was taken into confidence at the onset of study. He was requested to keep records in his own language, of the patients' overt aggressive behaviour shown in course of one week. He would then accompany the patient to the hospital once a week for the total six weeks of trial.
These patients were started with 500-750 mg. of lithium carbonate in two to three divided doses. Every week the lithium dose was adjusted according to clinical judgement, emergence of side effects and serum lithium estimation which was clone fortnightly. The side effects if .iny were noted at the same time. The patients were assessed every week on an 'Aggression Scale' with the help of relatives's data. The scale had tw > parameters; (1) the frequency and (2) the severity of aggressive outbursts shown by the patient during the last wet k. Each parameter was scored on a scale fiom 0 to 7. Tl e aggression score for the -week was obtained by multiplication of the two scores (Aggression scere of the week = Frequency score x severity scon"). The clinicians global impression about aggressive behaviour was reccrded each time. Kidney function test and h' mogram, pre ar.d post (rial period were reconled. The results at week 0 and week 6 were compared and analysed using paired *'t' test.
KliSULTS
The demographic data of these patients is shown in Table 1. Table 2 shows underlying psychiatric diagnosis of these patients, for which they underwent adequate treatment, before they were declared resistant and included in this trial.
As shown by Table 3 , 14 out of 20 patients showed m< derate to marked reduction in aggression as shown by clinical global impression scale at the end of the trial. The comparison between the initial aggression score and that at sixth week showed significant statistical difference (t=3.26, p<.01). The lithium carbonate dose ranged from 750 to 1200 mg. and serum lithium level ranged from 0.75 to 1.2 mEq/lt. The patients accepted the tablets regularly as judged by relatives data and periodic serum lithium estimation. There were no serious side effects noted during the trial and kidney function tests and hemogram remained unchanged at the end of the trial in all the patients.
There were four drop outs from study. All the patients dropped out within first two weeks of study, for reasons not known to us.
DISCUSSION
It is difficult to define aggression and even more so to quantify it. All the studies cited were carried out on indoor patients and used different methods to quantify aggression. We devised our own scale to measure acts of aggression. Our study, in contrast to ones quoted, was carried out on outdoor basis and that too on treatment resistent cases. We found that seventy percent of our patients showed moderate to marked improvement. The reduction in aggression score was also found to be highly significant. We consider our results very encouraging.
